Clinical Investigation of Cases Prescribed [Given] Epipen at Sunagawa City Medical Center

2011 ◽  
Vol 73 (2) ◽  
pp. 186-189
Author(s):  
Keiko NAKAHASHI ◽  
Asako KAMADA
Keyword(s):  
Clinical Investigation ◽  
Medical Center

Idiopathic Papular Dermatitis in the Spectrum of Chronic Papular Eruptions (Subacute Prurigo): Reappraisal and Diagnostic Algorithm

Dermatology ◽  
2019 ◽  
Vol 235 (3) ◽  
pp. 205-212
Author(s):  
Ayelet Ollech ◽  
Emmilia Hodak ◽  
Michael David ◽  
Akiva Trattner ◽  
Elena Didkovsky ◽  
...  
Keyword(s):  
Skin Diseases ◽  
Clinical Investigation ◽  
Morphological Changes ◽  
Medical Center ◽  
Age At Onset ◽  
Diagnostic Algorithm ◽  
Papular Eruption ◽  
Wide Range ◽  
Changes Over Time ◽  
Papular Dermatitis

Background: The clinical diagnosis of papular eruptions is common but poorly characterized in the literature and the etiology is often unknown. Objective: To characterize the entity of idiopathic papular dermatitis in the spectrum of chronic papular eruptions. Methods: The cohort consisted of patients who presented at a tertiary medical center in 2005–2014 with a papular eruption of at least 4 months’ duration. Findings on histological analysis and thorough clinical investigation, performed in all cases, were collected. The patients completed a questionnaire on disease course and outcome. Results: Sixty-five patients were included. Sixteen patients showed morphological changes over time and were excluded. Investigations in the remaining 49 patients with a consistent papular morphology yielded a well-defined diagnosis in 23 (46%). Twenty-six patients (54%; 14 male) were diagnosed with idiopathic papular dermatitis. Their mean age at onset was 61.6 ± 14.4 years and the mean duration of disease 3.11 ± 2.726 years. In 60%, the rash resolved with conservative treatment during follow-up (mean 4.35 ± 2.53 years). Conclusions: Chronic papular eruptions encompass a wide range of skin diseases. In more than half of the cases, the etiopathogenesis remains unclear. On the basis of our results, we propose a diagnostic algorithm for idiopathic papular dermatitis.

Significance of panendoscopy and CT in the follow-up and management of squamous cell carcinoma of the head and neck: A retrospective clinical assessment.

2013 ◽  
Vol 31 (15_suppl) ◽  
pp. e17003-e17003
Author(s):  
Adrian Muenscher ◽  
Susanne Sehner ◽  
Jegane Taleh ◽  
Silke Tribius ◽  
Carsten Dalchow ◽  
...  
Keyword(s):  
Head And Neck ◽  
Squamous Cell ◽  
Structural Information ◽  
Clinical Investigation ◽  
Medical Center ◽  
Tnm Staging ◽  
Histological Evaluation ◽  
Female Ratio ◽  
Male Predominance

e17003 Background: Treatment of patients with head and neck squamous cell carcinomas (HNSCC) require an evidence-based multidisciplinary approach which varies from medical centres. Panendoscopy has been traditionally used as a routine screening examination tool. We discuss and compare its clinical effectiveness, safety and predictive value in patients with computed tomography (CT) scans in a routine outpatient follow up. Methods: Between 2004-2007, in a retrospective study (204 patients; male:156 (76.5%); female:48 (23.5%))with head and neck cancer, fulfilled all inclusion and exclusion criteria were evaluated at the University Medical Center Hamburg-Eppendorf, Germany. Follow-ups were performed every 2 to 3 months for the first 3 years and every 6 month for the following 2 years. UICC-TNM staging system divided patients into seven categories. Results: The mean age of patients was (male: 59.2±9.3 years; female: 59.5±10.2 years), the highest incidence rate was recorded in the 51 to 60 age group (n = 77). There was a male predominance, with a male/female ratio of 3:1. In comparing normal versus abnormal CT a 12-fold higher frequency of recurrence (odds ratio [OR]; 95% CI: 3.99, 37.51; p<0.001) was interpreted.Additionally, patient anamnesis (OR: 3.33; 95% CI: 1.57, 7.07; p=0.002), clinical investigation (OR: 5.85; 95% CI: 3.01,11.36; p<0.001) and recurrence pattern (OR: 4.82; 95% CI: 2.26,10.32; p<0.001) was observed. Conclusions: In staging / follow-up HNSCC patients, CT-diagnostics also provided similar levels of accuracy as panendoscopy. Panendoscopy in patients with HNSCC was avoided (169 out of 364) when the diagnostic parameters remained satisfactory. Higher patient satisfaction, structural information at a high spatial resolution and comfort was noted in the CT group, indicating a gradual move towards CT diagnostics. For safety-related reasons in particular, we recommend panendoscopy for histological evaluation i.e.in predicting cancer recurrence and progression.

Milton Packer, MD, Director, Center for Biostatistics and Clinical Science at UT Southwestern

2004 ◽  
Vol 52 (7) ◽  
pp. 421-424
Keyword(s):  
Heart Failure ◽  
New York ◽  
Health Care Policy ◽  
Clinical Investigation ◽  
Medical Center ◽  
Heart Association ◽  
Clinical Science ◽  
Columbia University ◽  
Cardiovascular Research ◽  
Editorial Boards

Milton Packer, MD, is the director of the Center for Biostatistics and Clinical Science and holder of The Gayle and Paul Stoffel Distinguished Chair in Cardiology. He is the former chief of the Division of Circulatory Physiology at the Columbia University College of Physicians and Surgeons and the past director of the Heart Failure Center at the Columbia-Presbyterian Medical Center in New York City. One of the leading experts in the pathophysiology and treatment of heart failure, Dr. Packer has made significant contributions to heart failure research and has been instrumental in the introduction of a number of new treatments. The author of more than 200 papers, he has won numerous honors for teaching and has lectured around the world on the treatment of heart failure, having been honored with a number of prestigious named lectureships. He has served or currently serves on the editorial boards of many major medical journals, including Circulation and the Journal of the American College of Cardiology. He has also been elected to a number of societies, including the American Society for Clinical Investigation. He is currently on the executive committees of both the American Heart Association and the American College of Cardiology and is past-president of the Heart Failure Society of America. Dr. Packer is a primary consultant to the National Institutes of Health and the US Food and Drug Administration on the management of heart failure and on matters related to cardiovascular research, drug development, and health care policy.

Department of Clinical Investigation, Annual Research Progress Report, Fiscal Year 2007 (Madigan Army Medical Center)

2007 ◽  
Author(s):  
Barbara Jones ◽  
Troy Patience ◽  
Lucy Atoigue ◽  
Athena Rayner ◽  
Mary Porreca ◽  
...  
Keyword(s):  
Clinical Investigation ◽  
Medical Center ◽  
Progress Report ◽  
Research Progress ◽  
Fiscal Year ◽  
Army Medical

Clinical Investigation of Recurrent Pneumonia in Adults: Analysis of Patients From Hallym University Medical Center

2004 ◽  
Vol 57 (1) ◽  
pp. 47 ◽  
Author(s):  
Kwang Seok Eom ◽  
Gang Jeon ◽  
Tae Rim Shin ◽  
Seung Hun Jang ◽  
Joon woo Bahn ◽  
...  
Keyword(s):  
Clinical Investigation ◽  
Medical Center ◽  
Recurrent Pneumonia
Sign in / Sign up

Export Citation Format

Share Document